Regulatory Summit North America 2024

• an explanation of EPA’s TSCA section 6 risk evaluation process for existing chemicals;
• a status update on current risk evaluation activities; and
• a discussion of EPA's efforts to gather and review chemical information earlier in the risk evaluation process

Kevin M. DeBell

Division Director, U.S. Environmental Protection Agency (EPA)

• overview of the TSCA enforcement program priorities and focus areas;
• description of recent developments in TSCA enforcement and litigation; and
• significant recent enforcement case resolutions

Greg Sullivan

Director, Waste and Chemical Enforcement Division, US EPA, Office of Enforcement and Compliance Assurance, USA

• recurring reporting requirements;
• ongoing reporting requirements;
• PFAS reporting rule; and
• reporting rules under development.

John J. Kowalski

Regulatory Affairs Lead, UL Solutions, USA

Challenges facing industry in the New Chemicals review process

• • pre-submission meetings
  • industry submissions and EPA review
    • what is reasonably foreseeable
    • customer uses
    • challenges with PMNs vs. LVEs
  • EPA decision / regulatory determination
    • reasonably foreseeable uses
    • base assumption
    • significant new use rules

Robert F Helminiak

Vice President of Legal and Government Relations, Society of Chemical Manufacturers & Affiliates (SOCMA), US

VIRTUAL PRESENTATION

• New chemicals program overview
• background
• review process
• program Improvements
• program statistics
• looking ahead

Shari Z. Barash

New Chemicals Division Director, US EPA

• highlights of the 2024 legislation year so far;
• what trends are we seeing; and
• what can we expect moving forward?

Melanie Rybar

Regulatory and Compliance Analyst, Enhesa Product Intelligence, USA

• brief overview of California’s Safer Consumer Products regulatory framework;
• summary of our current work regulating chemicals in consumer products—identifying new Priority Products, evaluating industry Alternatives Analysis submittals, selecting regulatory responses; and
• looking ahead: the 2024-26 Priority Product Work Plan, new initiatives.

André Algazi

Manager, Chemical and Product Evaluation Branch, California Department of Toxic Substances Control

• review of state regulatory action on specific substances;
• contrast with federal efforts to regulate those same substances;
• case studies with substances such as 1,4 Dioxane and 6PPD; and
• lessons learned and path forward

Judah Prero

Counsel, Arnold & Porter, USA

• most significant state-level PFAS legislation trends in 2024;
• impact on companies of state-level legislation; and
• looking ahead: state legislation ahead in 2025 (and beyond)

John Gardella

Co-Owner / Attorney, CMBG3 Law, USA

• review the definitions of article according to various regulations of TSCA, OSHA, GHS; and
• explore some recent changes in scope for the definitions

Rose Passarella

Director - Chemicals Group, Intertek Assuris, USA

• what is Chevron Deference?;
• the Loper Bright decision; and
• implications for EPA, and TSCA in particular.

Lynn L. Bergeson

Managing Partner of Bergeson & Campbell, P.C. (B&C®) and President of The Acta Group, L.L.C. (Acta®), Bergeson & Campbell, USA